|
已选(0)清除
条数/页： 排序方式： |
| MAFG-AS1/MAFG positive feedback loop contributes to cisplatin resistance in bladder urothelial carcinoma through antagonistic ferroptosis 期刊论文
Science Bulletin, 2021, 卷号: 66, 期号: 17
作者: Xiang L.; Zeng Q.; Liu J.; Xiao M.; He D.; Zhang Q.; Xie D.; Deng M.; Zhu Y.; Liu Y.; Bo H.; Liu X.; Zhou M.; Xiong W.; Zhou Y.; Zhou J.; Li X.; Cao K.
  收藏 | 浏览/下载：28/0 | 提交时间：2021/09/01
Bladder urothelial carcinoma Chemosensitivity Cisplatin Ferroptosis MAFG-AS1 |
| Schizophrenia risk-gene Crmp2 deficiency causes precocious critical period plasticity and deteriorated binocular vision 期刊论文
Science Bulletin, 2021
作者: Zhang Y.; Yao L.; Li X.; Meng M.; Shang Z.; Wang Q.; Xiao J.; Gu X.; Xu Z.; Zhang X.
收藏 | 浏览/下载：32/0 | 提交时间：2021/09/01
Binocular depth perception Collapsin response mediator protein-2 (CRMP2) Critical period plasticity Excitation-inhibition balance Primary visual cortex Schizophrenia |
| Whole genome analyses reveal significant convergence in obsessive-compulsive disorder between humans and dogs 期刊论文
Science Bulletin, 2021, 卷号: 66, 期号: 2
作者: Cao X.; Liu W.-P.; Cheng L.-G.; Li H.-J.; Wu H.; Liu Y.-H.; Chen C.; Xiao X.; Li M.; Wang G.-D.; Zhang Y.-P.
收藏 | 浏览/下载：36/0 | 提交时间：2021/09/01
Circling behavior Domestic dogs Genetic convergence Obsessive-compulsive disorder Whole genome sequencing |
| A pig model carrying heterozygous point mutation of NCSTN simulates familial acne inversa and reveals dysregulated cholesterol biosynthesis via the Notch-pAMPK-HMGCR pathway 期刊论文
Science Bulletin, 2021
作者: Song R.; Liu K.; Wang Y.; Qin G.; Xiao M.; Liu Y.; Yang J.; Zong R.; Yan X.; Zheng Q.; Zhang H.; Hou N.; Yao J.; Wang X.; Wang Y.; Zhao J.; Zhang X.
收藏 | 浏览/下载：29/0 | 提交时间：2021/09/01 |
| Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS) 期刊论文
Science Bulletin, 2021, 卷号: 66, 期号: 15
作者: Jia W.; Ma J.; Miao H.; Wang C.; Wang X.; Li Q.; Lu W.; Yang J.; Zhang L.; Yang J.; Wang G.; Zhang X.; Zhang M.; Sun L.; Yu X.; Du J.; Shi B.; Xiao C.; Zhu D.; Liu H.; Zhong L.; Xu C.; Xu Q.; Liang G.; Zhang Y.; Li G.; Gu M.; Liu J.; Yuan G.; Yan Z.; Yan D.; Ye S.; Zhang F.; Ning Z.; Cao H.; Pan D.; Yao H.; Lu X.; Ji L.
收藏 | 浏览/下载：39/0 | 提交时间：2021/09/01
Chiglitazar Glycemic control Insulin resistance PPAR pan-agonist Type 2 diabetes |
